ADN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Advent Technologies Holdings Inc (ADN).


$13.93M Market Cap.

As of 08/14/2024 5:00 PM ET (MRY) • Disclaimer

ADN Market Cap. (MRY)


ADN Shares Outstanding (MRY)


ADN Assets (MRY)


Total Assets

$34.74M

Total Liabilities

$21.29M

Total Investments

$750.00K

ADN Income (MRY)


Revenue

$4.86M

Net Income

-$71.40M

Operating Expense

$56.91M

ADN Cash Flow (MRY)


CF Operations

-$32.12M

CF Investing

-$6.23M

CF Financing

$9.06M

ADN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

ADN Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$34,737,000 (-61.23%)

$89,588,000 (-45.05%)

$163,031,000 (8507.48%)

$1,894,061 (-0.66%)

Assets Current

$8,835,000 (-82.15%)

$49,500,000 (-49.15%)

$97,351,000 (5642.78%)

$1,695,188 (-6.93%)

Assets Non-Current

$25,902,000 (-35.39%)

$40,088,000 (-38.96%)

$65,680,000 (32926.10%)

$198,873 (133.69%)

Goodwill & Intangible Assets

$79,000 (-99.33%)

$11,804,000 (-77.88%)

$53,374,000 (0%)

$0 (0%)

Shareholders Equity

$13,448,000 (-79.04%)

$64,148,000 (-50.73%)

$130,201,000 (7359.71%)

-$1,793,473 (-115.10%)

Property Plant & Equipment Net

$24,765,000 (12.60%)

$21,993,000 (156.18%)

$8,585,000 (4219.78%)

$198,737 (133.87%)

Cash & Equivalents

$3,662,000 (-88.86%)

$32,869,000 (-58.79%)

$79,764,000 (15366.11%)

$515,734 (-56.99%)

Accumulated Other Comprehensive Income

-$2,334,000 (10.37%)

-$2,604,000 (-104.56%)

-$1,273,000 (-1238.84%)

$111,780 (-5.96%)

Deferred Revenue

$2,865,000 (53.21%)

$1,870,000 (41.35%)

$1,323,000 (160.00%)

$508,853 (95.66%)

Total Investments

$750,000 (-29.91%)

$1,070,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$750,000 (-29.91%)

$1,070,000 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,707,000 (-78.55%)

$12,620,000 (81.37%)

$6,958,000 (6346.23%)

$107,939 (232.73%)

Trade & Non-Trade Receivables

$191,000 (-80.49%)

$979,000 (-68.81%)

$3,139,000 (542.13%)

$488,840 (54.48%)

Trade & Non-Trade Payables

$5,087,000 (8.70%)

$4,680,000 (-3.25%)

$4,837,000 (142.33%)

$1,996,053 (28.67%)

Accumulated Retained Earnings (Deficit)

-$179,159,000 (-66.25%)

-$107,762,000 (-222.40%)

-$33,425,000 (-159.08%)

-$12,901,518 (-32.08%)

Tax Assets

$0 (0%)

$0 (0%)

$1,246,000 (0%)

$0 (0%)

Tax Liabilities

$179,000 (-2.19%)

$183,000 (-93.21%)

$2,696,000 (1236.11%)

$201,780 (4.01%)

Total Debt

$10,416,000 (-13.79%)

$12,082,000 (0%)

$0 (0%)

$0 (0%)

Debt Current

$2,186,000 (-4.12%)

$2,280,000 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$8,230,000 (-16.04%)

$9,802,000 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$21,289,000 (-16.32%)

$25,440,000 (-22.51%)

$32,830,000 (790.30%)

$3,687,534 (34.56%)

Liabilities Current

$11,913,000 (-12.83%)

$13,666,000 (-27.58%)

$18,871,000 (450.37%)

$3,428,792 (35.47%)

Liabilities Non-Current

$9,376,000 (-20.37%)

$11,774,000 (-15.65%)

$13,959,000 (5294.95%)

$258,742 (23.60%)

ADN Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$4,859,000 (-38.00%)

$7,837,000 (10.86%)

$7,069,000 (700.88%)

$882,652 (42.32%)

Cost of Revenue

$18,287,000 (113.11%)

$8,581,000 (58.73%)

$5,406,000 (952.12%)

$513,818 (29.30%)

Selling General & Administrative Expense

$32,468,000 (-9.60%)

$35,915,000 (-14.24%)

$41,877,000 (1080.68%)

$3,546,856 (310.72%)

Research & Development Expense

$12,112,000 (23.64%)

$9,796,000 (176.65%)

$3,541,000 (3353.35%)

$102,538 (-17.79%)

Operating Expenses

$56,913,000 (-32.79%)

$84,683,000 (85.00%)

$45,774,000 (1229.65%)

$3,442,566 (768.21%)

Interest Expense

-$74,000 (-42.31%)

-$52,000 (-201.96%)

$51,000 (820.25%)

$5,542 (-94.80%)

Income Tax Expense

$719,000 (136.50%)

-$1,970,000 (-113.43%)

-$923,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$71,397,000 (3.95%)

-$74,337,000 (-262.21%)

-$20,523,000 (-557.57%)

-$3,121,042 (-771.18%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$71,397,000 (3.95%)

-$74,337,000 (-262.21%)

-$20,523,000 (-557.57%)

-$3,121,042 (-771.18%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$71,397,000 (3.95%)

-$74,337,000 (-262.21%)

-$20,523,000 (-557.57%)

-$3,121,042 (-771.18%)

Weighted Average Shares

$1,917,179 (-96.28%)

$51,528,703 (12.47%)

$45,814,868 (123.28%)

$20,518,894 (206.44%)

Weighted Average Shares Diluted

$1,917,179 (-96.28%)

$51,528,703 (12.47%)

$45,814,868 (123.28%)

$20,518,894 (206.44%)

Earning Before Interest & Taxes (EBIT)

-$70,752,000 (7.34%)

-$76,359,000 (-256.90%)

-$21,395,000 (-586.73%)

-$3,115,500 (-1802.37%)

Gross Profit

-$13,428,000 (-1704.84%)

-$744,000 (-144.74%)

$1,663,000 (350.88%)

$368,834 (65.56%)

Operating Income

-$70,341,000 (17.66%)

-$85,427,000 (-93.66%)

-$44,111,000 (-1335.10%)

-$3,073,732 (-1669.19%)

ADN Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$6,234,000 (57.06%)

-$14,517,000 (43.20%)

-$25,556,000 (-20760.68%)

-$122,508 (-250.67%)

Net Cash Flow from Financing

$9,059,000 (22747.50%)

-$40,000 (-100.03%)

$141,501,000 (15937.20%)

$882,330 (-34.67%)

Net Cash Flow from Operations

-$32,115,000 (0.03%)

-$32,125,000 (10.36%)

-$35,837,000 (-2414.76%)

-$1,425,068 (-513.03%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$29,290,000 (37.26%)

-$46,682,000 (-158.27%)

$80,108,000 (12141.86%)

-$665,246 (-161.41%)

Net Cash Flow - Business Acquisitions and Disposals

-$1,864,000 (0%)

$0 (0%)

-$19,425,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

-$316,000 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$4,370,000 (68.97%)

-$14,084,000 (-130.39%)

-$6,113,000 (-4889.88%)

-$122,508 (-250.67%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$40,000 (-133.90%)

$118,000 (123.60%)

-$500,000 (0%)

Issuance (Purchase) of Equity Shares

$9,059,000 (0%)

$0 (0%)

$141,383,000 (296655.85%)

-$47,675 (-3240.65%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$83,000 (-84.54%)

$537,000 (162.44%)

-$860,000 (-4668.51%)

-$18,035 (42.94%)

Share Based Compensation

$9,881,000 (-5.12%)

$10,414,000 (35.09%)

$7,709,000 (786.62%)

$869,481 (0%)

Depreciation Amortization & Accretion

$3,647,000 (-14.33%)

$4,257,000 (144.09%)

$1,744,000 (7648.36%)

$22,508 (33.94%)

ADN Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-276.40% (-2809.47%)

-9.50% (-140.43%)

23.50% (-43.78%)

41.80% (16.43%)

Profit Margin

-1469.40% (-54.92%)

-948.50% (-226.73%)

-290.30% (17.90%)

-353.60% (-511.76%)

EBITDA Margin

-1381.00% (-50.11%)

-920.00% (-230.94%)

-278.00% (20.66%)

-350.40% (-1378.48%)

Return on Average Equity (ROAE)

-202.30% (-184.53%)

-71.10% (-318.24%)

-17.00% (89.58%)

-163.10% (-1514.85%)

Return on Average Assets (ROAA)

-121.60% (-105.41%)

-59.20% (-335.29%)

-13.60% (-312.12%)

-3.30% (-1550.00%)

Return on Sales (ROS)

-1456.10% (-49.45%)

-974.30% (-221.87%)

-302.70% (14.25%)

-353.00% (-1237.12%)

Return on Invested Capital (ROIC)

-166.10% (40.29%)

-278.20% (1.28%)

-281.80% (-204.68%)

269.20% (1163.85%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.18 (85.76%)

-1.26 (91.93%)

-15.58 (84.35%)

-99.53 (50.82%)

Price to Sales Ratio (P/S)

2.64 (-77.84%)

11.9 (-73.80%)

45.43 (-86.91%)

347.08 (217.65%)

Price to Book Ratio (P/B)

1.04 (-28.99%)

1.46 (-47.12%)

2.76 (102.27%)

-121.32 (63.74%)

Debt to Equity Ratio (D/E)

1.58 (298.74%)

0.4 (57.54%)

0.25 (112.26%)

-2.06 (37.45%)

Earnings Per Share (EPS)

-37.24 (-2486.11%)

-1.44 (-220.00%)

-0.45 (-200.00%)

-0.15 (-200.00%)

Sales Per Share (SPS)

2.53 (1567.11%)

0.15 (-1.30%)

0.15 (258.14%)

0.04 (-53.76%)

Free Cash Flow Per Share (FCFPS)

-19.03 (-2021.63%)

-0.9 (2.07%)

-0.92 (-1121.33%)

-0.07 (-87.50%)

Book Value Per Share (BVPS)

7.01 (463.37%)

1.25 (-56.19%)

2.84 (3366.67%)

-0.09 (30.40%)

Tangible Assets Book Value Per Share (TABVPS)

18.08 (1097.22%)

1.51 (-36.90%)

2.39 (2501.09%)

0.09 (-67.72%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (91.67%)

-12 (42.86%)

-21 (93.62%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.29 (59.30%)

-0.71 (94.77%)

-13.58 (36.40%)

-21.35 (94.17%)

Asset Turnover

0.08 (33.87%)

0.06 (31.91%)

0.05 (422.22%)

0.01 (125.00%)

Current Ratio

0.74 (-79.51%)

3.62 (-29.79%)

5.16 (944.33%)

0.49 (-31.39%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$36,485,000 (21.04%)

-$46,209,000 (-10.15%)

-$41,950,000 (-2610.69%)

-$1,547,576 (-478.76%)

Enterprise Value (EV)

$19,366,958 (-62.15%)

$51,163,073 (-80.82%)

$266,795,306 (304.04%)

$66,031,230 (22.61%)

Earnings Before Tax (EBT)

-$70,678,000 (7.38%)

-$76,307,000 (-255.81%)

-$21,446,000 (-587.14%)

-$3,121,042 (-1054.12%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$67,105,000 (6.93%)

-$72,102,000 (-266.91%)

-$19,651,000 (-535.34%)

-$3,092,992 (-2004.58%)

Invested Capital

$29,499,000 (-31.92%)

$43,331,000 (293.13%)

$11,022,000 (637.54%)

-$2,050,465 (-54.93%)

Working Capital

-$3,078,000 (-108.59%)

$35,834,000 (-54.34%)

$78,480,000 (4626.99%)

-$1,733,604 (-144.32%)

Tangible Asset Value

$34,658,000 (-55.44%)

$77,784,000 (-29.07%)

$109,657,000 (5689.52%)

$1,894,061 (-0.66%)

Market Capitalization

$13,931,958 (-85.12%)

$93,609,073 (-73.95%)

$359,287,673 (65.12%)

$217,592,134 (-22.00%)

Average Equity

$35,289,250 (-66.25%)

$104,569,250 (-13.17%)

$120,423,810 (6193.79%)

$1,913,374 (-45.97%)

Average Assets

$58,721,500 (-53.27%)

$125,652,750 (-16.87%)

$151,160,968 (57.83%)

$95,773,236 (-43.19%)

Invested Capital Average

$42,589,750 (55.16%)

$27,448,750 (261.54%)

$7,592,141 (755.90%)

-$1,157,514 (-50.48%)

Shares

2,084,374 (-95.97%)

51,717,720 (0.91%)

51,253,591 (251.67%)

14,574,155 (-47.13%)